FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZANIDATAMAB
异名/同义词ANTI-HER2 BI-SPECIFIC MONOCLONAL ANTIBODY ZW25
IMMUNOGLOBULIN G1, ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 LIGHT CHAIN VARIABLE REGION FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 20-AMINO ACID LINKER) FUSION PROTEIN WITH HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 HEAVY CHAIN VARIABLE REGION FRAGMENT FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 2-AMINO ACID LINKER) FUSION PROTEIN WITH HUMAN FC FRAGMENT, (261->229'),(264->232')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 .KAPPA.-CHAIN
JZP598
ZANIDATAMAB
ZANIDATAMAB [INN]
ZANIDATAMAB [USAN]
ZANIDATAMAB [WHO-DD]
ZANIDATAMAB HRII [WHO-DD]
ZANIDATAMAB-HRII
ZIIHERA
ZW25
ZW-25
CAS登记号2169946-15-8
物质唯一标识(Unique Ingredient Identifier)Z20OC92TDI
分子式Z20OC92TDI
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System